---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-032826"
form_type: "8-K"
ticker: "AVIR"
cik: "0001593899"
company_name: "Atea Pharmaceuticals, Inc."
filed_at: "2025-02-24T23:59:59+00:00"
generated_at: "2026-05-26T05:54:27.822645+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Atea Pharmaceuticals appoints Arthur Kirsch to Board of Directors

## Summary
- Arthur Kirsch, age 73, elected as Class I director effective February 20, 2025.
- Kirsch brings experience as Senior Advisor at Alvarez & Marsal Life Sciences Industry Group.
- Annual cash retainer of $45,000 plus initial option to purchase 164,800 shares vesting over 36 months.
- Kirsch currently serves on board of Liquidia Technologies (LQDA); previously on boards of Kadmon, Immunomedics, POZEN, Aralez.
- Compensation follows Non-Employee Director Compensation Program disclosed in Q2 2024 Form 10-Q.

## SEC filing metadata
- accession: 0001193125-25-032826
- form_type: 8-K
- ticker: AVIR
- cik: 0001593899
- company_name: Atea Pharmaceuticals, Inc.
- filed_at: 2025-02-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1593899/000119312525032826/0001193125-25-032826-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1593899/000119312525032826/d918567d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-032826
- JSON: https://secwatch.observer/filing/0001193125-25-032826.json
- Plain text: https://secwatch.observer/filing/0001193125-25-032826.txt

## Key facts
- Executive change
  Arthur Kirsch was elected as Class I director at Atea Pharmaceuticals, Inc..
  - Action: elected
  - Role: Class I director
  source text: On February 20, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Atea Pharmaceuticals, Inc. (the “Company”) elected Arthur Kirsch as a Class I director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1593899/000119312525032826/0001193125-25-032826-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.